UPDATE: SpringWorks Therapeutics Announces FDA Approval of GOMEKLI™ (mirdametinib) for the Treatment of Adult and Pediatric Patients with NF1-PN

UPDATE: SpringWorks Therapeutics Announces FDA Approval of GOMEKLI™ (mirdametinib) for the Treatment of…

www.investing.com

More posts

Pakistan train hijack hostages end ordeal with arrival in Quetta

March 13, 2025
Delta Honored Among Clarivate's Global Top 100 Innovators for the Fourth Consecutive Year

March 13, 2025
Trump’s chief economist has a blueprint to force countries to pay for tariffs without reigniting inflation, but he says the path to success is narrow

March 13, 2025
Hyundai Motor Group Takes Top Honors for Safety with Industry-leading 12 Titles in Updated 2025 IIHS Safety Awards

March 13, 2025